Antiphospholipid antibodies and the protein C pathway.
Among the mechanisms suggested for the prothrombotic activity of lupus anticoagulant and antiphospholipid antibodies is the direct inhibition of the anticoagulant activated protein C (APC) pathway. Although some pathological antibodies may be directed towards the proteins involved, we hypothesize that populations exist which selectively inhibit the APC complex as a result of differences in the phospholipid requirements of this complex as compared to those of the procoagulant complexes. The most prominent feature is the requirement for the presence of phosphatidylethanolamine in the membrane for APC anticoagulant function. This mimics the requirements for inhibitory activity of at least a subset of autoantibodies associated with thrombosis. The role of oxidation of the phospholipid in APC function and antibody reactivity is also discussed.
Esmon
N L
NL
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, 73104, USA. Naomi-Esmon@omrf.ouhsc.edu
Safa
O
O
Smirnov
M D
MD
Esmon
C T
CT
D017152:Antibodies, Antiphospholipid / Q000097:blood*; D001777:Blood Coagulation / Q000276:immunology*; D006801:Humans; D010084:Oxidation-Reduction; D011486:Protein C / Q000378:metabolism / Q000502:physiology*
D017152:Antibodies, Antiphospholipid; D011486:Protein C